Phase IIIb Randomized Trial Comparing Irradiation Plus Long Term Adjuvant Androgen Deprivation With GnRH Antagonist Versus GnRH Agonist Plus Flare Protection in Patients With Very High Risk Localized or Locally Advanced Prostate Cancer. A Joint Study of the EORTC ROG and GUCG
Phase of Trial: Phase III
Latest Information Update: 02 Apr 2018
At a glance
- Drugs Degarelix (Primary)
- Indications Prostate cancer
- Focus Therapeutic Use
- Acronyms PEGASUS
- 27 Sep 2017 Status changed from not yet recruiting to recruiting.
- 16 Jan 2017 Planned initiation date changed from 1 Oct 2016 to 1 Apr 2017.
- 29 Jun 2016 New trial record